Compare ALTG & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALTG | TNYA |
|---|---|---|
| Founded | 1984 | 2016 |
| Country | United States | United States |
| Employees | 2900 | N/A |
| Industry | Industrial Machinery/Components | Medicinal Chemicals and Botanical Products |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 207.2M | 217.0M |
| IPO Year | N/A | 2021 |
| Metric | ALTG | TNYA |
|---|---|---|
| Price | $6.18 | $0.83 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $11.33 | $5.33 |
| AVG Volume (30 Days) | 312.1K | ★ 4.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 0.77% | N/A |
| EPS Growth | N/A | ★ 54.96 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $4.85 | N/A |
| Revenue Next Year | $3.06 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.16 | $0.39 |
| 52 Week High | $8.88 | $2.35 |
| Indicator | ALTG | TNYA |
|---|---|---|
| Relative Strength Index (RSI) | 41.21 | 52.35 |
| Support Level | $6.25 | $0.65 |
| Resistance Level | $6.73 | $0.94 |
| Average True Range (ATR) | 0.56 | 0.08 |
| MACD | -0.22 | 0.01 |
| Stochastic Oscillator | 8.69 | 36.55 |
Alta Equipment Group Inc is an integrated equipment dealership platform in the U.S. Its segments are Material Handling, Construction Equipment, and Master Distribution. The Material Handling segment is engaged in operations related to the sale, service, and rental of lift trucks in Michigan, Illinois, Indiana, New York, Virginia, and throughout the New England states whereas, the Construction Equipment segment is principally engaged in operations related to the sale, service, and rental of construction equipment in Michigan, Indiana, Illinois, Ohio, Pennsylvania, New York, Florida and throughout the New England States, and The Master Distribution segment is engaged in environmental processing equipment distribution with sub dealers throughout the United States and Canada.
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.